Hyperbaric Oxygen in Diabetic Gangrene Treatment
- Giancarlo Baroni, MD,
- Tommaso Porro, MD,
- Ezio Faglia, MD,
- Gianluigi Pizzi, MD,
- Arturo Mastropasqua, MD,
- Giorgio Oriani, MD,
- Giorgio Pedesini, MD and
- Favales Favales, MD
- Center of Diabetology and Metabolic Diseases, Ospedale Niguarda Cà Granda Milan, Italy
- Service of Anesthesiology, Instituto Ortopedico Galeazzi Milan, Italy
- Send correspondence and reprint requests to Dr. Ezio Faglia, Via Monte Generoso, 50, 20155 Milan, Italy.
Abstract
We treated a group of 18 hospitalized adult diabetic patients (all with retinopathy, 17 with symptomatic neuropathy, and 6 with macroangiopathy) presenting with gangrenous lesions of the foot by a combined regime consisting of strict metabolic control, daily debridement of necrotic tissues, and daily hyperbaric oxygen (HBO) treatments given in a multiplace oxygen chamber. Another group of 10 adult subjects with comparable foot lesions (all with retinopathy, 9 with symptomatic neuropathy, and 4 with macroangiopathy) was treated in exactly the same way except for HBO. In the test treatment group, 16 patients were healed, and the remaining 2 showed no improvement and later underwent amputation.
The number of HBO treatments required for healing was significantly related to the size of gangrenous lesions. In the non-HBO-treated group, only 1 patient improved, 5 of 10 showed no change, and 4 of 10 worsened until leg amputation was unavoidable. Comparison of the two groups by X2-test revealed a highly significant difference (P = .001). In practical terms, HBO treatment drastically reduced leg amputations in patients so treated in the last 3 yr compared with earlier and current figures for patients not receiving HBO treatment.
- Copyright © 1987 by the American Diabetes Association











